DAM
CYTK icon

DLD Asset Management’s Cytokinetics CYTK Stock Holding History

DLD Asset Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$852K Buy
10,000
+2,500
+33% +$180K 0.06% 230
2026
Q1 		$494K Buy
+7,500
New +$477K 0.04% 217
2025
Q4 		– Sell
-25,000
Closed -$1.37M – 401
2025
Q3 		$1.37M Buy
+25,000
New +$1.03M 0.1% 129

Other funds holding CYTK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DLD Asset Management's CYTK Position: Q4 2025 in Review

DLD Asset Management sold out of Cytokinetics (CYTK) in Q4 2025, closing a stake of 11,000 shares — an estimated $605K sold.

DLD Asset Management first reported a position in CYTK in Q3 2025 and held it in 1 quarter. The position peaked at $605K in Q3 2025. 431 funds tracked by Wall St. Rank hold CYTK as of Q4 2025.

  • DLD Asset Management reported no remaining Cytokinetics position as of Q4 2025 after selling out during the quarter.
  • DLD Asset Management sold 11,000 Cytokinetics shares in Q4 2025, an estimated $605K.
  • DLD Asset Management first reported a position in Cytokinetics in Q3 2025 and held it in 1 quarter.
  • DLD Asset Management's Cytokinetics position peaked at $605K in Q3 2025.
  • 431 funds tracked by Wall St. Rank held Cytokinetics as of Q4 2025.

Based on DLD Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.